Monthly prophylactic fitusiran injections effective in reducing bleeds in patients with hemophilia A or B
Monthly prophylactic injections of fitusiran are effective in reducing bleeds in patients with hemophilia A or B, according to randomized controlled trials publishing simultaneously in The Lancet and The Lancet Haematology journals.
United States Los Angeles Emily Henderson Lancet Haematology Professor Guy Young Hospital Los Angeles
Source: news-medical.net